Last update 11 Apr 2026

Allogeneic B lymphoblastoid cells expressing multiple Epstein-Barr virus antigens (CR Therapeutics)

Overview

Basic Info

Drug Type
Cell therapy
Synonyms
CR101
Target
EBV Protein
Action
inhibitors
Mechanism
EBV Protein inhibitors
Therapeutic Areas
NeoplasmsMouth and Tooth DiseasesOtorhinolaryngologic Diseases+ [1]
Active Indication
Epstein-Barr virus associated NeoplasmsNasopharyngeal Carcinoma
Inactive Indication-
Originator Organization
CR Therapeutics Co., Ltd.
Active Organization
West China HospitalWest China HospitalCR Therapeutics Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
RegulationOrphan Drug (United States)
Login to view timeline

Related

1
Clinical Trials associated with Allogeneic B lymphoblastoid cells expressing multiple Epstein-Barr virus antigens (CR Therapeutics)
NCT05707910
/ Active, not recruitingPhase 1IIT
A Phase I Study of the Efficacy and Safety of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors
100 Clinical Results associated with Allogeneic B lymphoblastoid cells expressing multiple Epstein-Barr virus antigens (CR Therapeutics)
Login to view more data
100 Translational Medicine associated with Allogeneic B lymphoblastoid cells expressing multiple Epstein-Barr virus antigens (CR Therapeutics)
Login to view more data
100 Patents (Medical) associated with Allogeneic B lymphoblastoid cells expressing multiple Epstein-Barr virus antigens (CR Therapeutics)
Login to view more data
100 Deals associated with Allogeneic B lymphoblastoid cells expressing multiple Epstein-Barr virus antigens (CR Therapeutics)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Epstein-Barr virus associated NeoplasmsPhase 1
China
West China HospitalWest China Hospital
08 Feb 2023
Nasopharyngeal CarcinomaPreclinical
China
CR Therapeutics Co., Ltd.
16 Apr 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free